Rank | Gene Set | Z-score |
---|---|---|
1 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.88136467 |
2 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88136467 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.82581781 |
4 | negative regulation of cell killing (GO:0031342) | 4.82581781 |
5 | L-phenylalanine catabolic process (GO:0006559) | 4.72767978 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.72767978 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.53597096 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.53597096 |
9 | aromatic amino acid family catabolic process (GO:0009074) | 4.38276768 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.32891690 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.27655499 |
12 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25512370 |
13 | tryptophan catabolic process (GO:0006569) | 4.11134361 |
14 | indole-containing compound catabolic process (GO:0042436) | 4.11134361 |
15 | indolalkylamine catabolic process (GO:0046218) | 4.11134361 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06881129 |
17 | urea metabolic process (GO:0019627) | 4.06297112 |
18 | urea cycle (GO:0000050) | 4.06297112 |
19 | kynurenine metabolic process (GO:0070189) | 4.04193531 |
20 | complement activation, alternative pathway (GO:0006957) | 4.03475420 |
21 | tryptophan metabolic process (GO:0006568) | 3.93526531 |
22 | bile acid biosynthetic process (GO:0006699) | 3.91590208 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90622955 |
24 | negative thymic T cell selection (GO:0045060) | 3.89304956 |
25 | protein carboxylation (GO:0018214) | 3.86677599 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86677599 |
27 | negative T cell selection (GO:0043383) | 3.86362291 |
28 | regulation of protein activation cascade (GO:2000257) | 3.77550497 |
29 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70861855 |
30 | cellular extravasation (GO:0045123) | 3.68738377 |
31 | negative regulation of fibrinolysis (GO:0051918) | 3.68713252 |
32 | detection of other organism (GO:0098543) | 3.68132127 |
33 | nitrogen cycle metabolic process (GO:0071941) | 3.64942970 |
34 | glyoxylate metabolic process (GO:0046487) | 3.61937199 |
35 | positive thymic T cell selection (GO:0045059) | 3.61084352 |
36 | sulfur amino acid catabolic process (GO:0000098) | 3.60478688 |
37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60379408 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59935787 |
39 | modulation by symbiont of host defense response (GO:0052031) | 3.59935787 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59935787 |
41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59935787 |
42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59935787 |
43 | modulation by symbiont of host immune response (GO:0052553) | 3.59935787 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 3.59108565 |
45 | valine metabolic process (GO:0006573) | 3.58095626 |
46 | regulation of complement activation (GO:0030449) | 3.57544681 |
47 | detection of bacterium (GO:0016045) | 3.56679668 |
48 | B cell receptor signaling pathway (GO:0050853) | 3.50005449 |
49 | cysteine metabolic process (GO:0006534) | 3.46662509 |
50 | regulation of fibrinolysis (GO:0051917) | 3.42469087 |
51 | phospholipid efflux (GO:0033700) | 3.41372301 |
52 | bile acid metabolic process (GO:0008206) | 3.37394733 |
53 | homocysteine metabolic process (GO:0050667) | 3.37010803 |
54 | reverse cholesterol transport (GO:0043691) | 3.35228204 |
55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.34064544 |
56 | protein-lipid complex remodeling (GO:0034368) | 3.34064544 |
57 | macromolecular complex remodeling (GO:0034367) | 3.34064544 |
58 | type I interferon signaling pathway (GO:0060337) | 3.33452782 |
59 | cellular response to type I interferon (GO:0071357) | 3.33452782 |
60 | response to type I interferon (GO:0034340) | 3.33427677 |
61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32764631 |
62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31142088 |
63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30360867 |
64 | negative regulation of sterol transport (GO:0032372) | 3.28980574 |
65 | negative regulation of cholesterol transport (GO:0032375) | 3.28980574 |
66 | immunoglobulin mediated immune response (GO:0016064) | 3.27952823 |
67 | lysine metabolic process (GO:0006553) | 3.25622698 |
68 | lysine catabolic process (GO:0006554) | 3.25622698 |
69 | T cell migration (GO:0072678) | 3.25052834 |
70 | amino-acid betaine metabolic process (GO:0006577) | 3.23298417 |
71 | positive regulation of B cell differentiation (GO:0045579) | 3.22791108 |
72 | plasma lipoprotein particle assembly (GO:0034377) | 3.22782519 |
73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21186014 |
74 | macrophage activation involved in immune response (GO:0002281) | 3.19184410 |
75 | plasma lipoprotein particle clearance (GO:0034381) | 3.18346382 |
76 | regulation of cholesterol esterification (GO:0010872) | 3.18177791 |
77 | bile acid and bile salt transport (GO:0015721) | 3.17382648 |
78 | positive T cell selection (GO:0043368) | 3.17050659 |
79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13739352 |
80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12589924 |
81 | response to interleukin-15 (GO:0070672) | 3.10923339 |
82 | T cell selection (GO:0045058) | 3.09339266 |
83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08878540 |
84 | aromatic amino acid family metabolic process (GO:0009072) | 3.08031458 |
85 | thymic T cell selection (GO:0045061) | 3.07470275 |
86 | phospholipid homeostasis (GO:0055091) | 3.06959261 |
87 | detection of external biotic stimulus (GO:0098581) | 3.05262601 |
88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.03718350 |
89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.03464146 |
90 | acylglycerol homeostasis (GO:0055090) | 3.02957526 |
91 | triglyceride homeostasis (GO:0070328) | 3.02957526 |
92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01101220 |
93 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.00420585 |
94 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.00420585 |
95 | serine family amino acid catabolic process (GO:0009071) | 2.98999510 |
96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98748988 |
97 | response to muramyl dipeptide (GO:0032495) | 2.97960030 |
98 | ethanol oxidation (GO:0006069) | 2.96910199 |
99 | tyrosine metabolic process (GO:0006570) | 2.96444444 |
100 | negative regulation of interleukin-12 production (GO:0032695) | 2.95542625 |
101 | glycine metabolic process (GO:0006544) | 2.94659567 |
102 | cholesterol efflux (GO:0033344) | 2.94304032 |
103 | cellular glucuronidation (GO:0052695) | 2.94035144 |
104 | germinal center formation (GO:0002467) | 2.93727281 |
105 | protein-lipid complex assembly (GO:0065005) | 2.93401259 |
106 | response to peptidoglycan (GO:0032494) | 2.92919990 |
107 | regulation of B cell differentiation (GO:0045577) | 2.91460337 |
108 | complement activation, classical pathway (GO:0006958) | 2.90191203 |
109 | regulation of T cell tolerance induction (GO:0002664) | 2.89493090 |
110 | complement activation (GO:0006956) | 2.88484894 |
111 | regulation of humoral immune response (GO:0002920) | 2.88475462 |
112 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86771812 |
113 | plasma lipoprotein particle organization (GO:0071827) | 2.85513670 |
114 | neutrophil activation involved in immune response (GO:0002283) | 2.85132519 |
115 | regulation of tolerance induction (GO:0002643) | 2.85068649 |
116 | leukocyte aggregation (GO:0070486) | 2.85061173 |
117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84693385 |
118 | indolalkylamine metabolic process (GO:0006586) | 2.83786453 |
119 | benzene-containing compound metabolic process (GO:0042537) | 2.83235196 |
120 | alpha-amino acid catabolic process (GO:1901606) | 2.83091886 |
121 | regulation of cholesterol homeostasis (GO:2000188) | 2.80592808 |
122 | protein activation cascade (GO:0072376) | 2.80008910 |
123 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78961612 |
124 | imidazole-containing compound metabolic process (GO:0052803) | 2.78884609 |
125 | cytolysis (GO:0019835) | 2.78059970 |
126 | 2-oxoglutarate metabolic process (GO:0006103) | 2.77362728 |
127 | acute-phase response (GO:0006953) | 2.74869377 |
128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.73629914 |
129 | cholesterol homeostasis (GO:0042632) | 2.72205590 |
130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72027228 |
131 | fibrinolysis (GO:0042730) | 2.71415523 |
132 | amine catabolic process (GO:0009310) | 2.70966002 |
133 | cellular biogenic amine catabolic process (GO:0042402) | 2.70966002 |
134 | protein-lipid complex subunit organization (GO:0071825) | 2.70858026 |
135 | regulation of antigen processing and presentation (GO:0002577) | 2.70851042 |
136 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.69831036 |
137 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.69831036 |
138 | NIK/NF-kappaB signaling (GO:0038061) | 2.69219492 |
139 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68979700 |
140 | sterol homeostasis (GO:0055092) | 2.68549225 |
141 | positive regulation of lipid catabolic process (GO:0050996) | 2.67737213 |
142 | detection of molecule of bacterial origin (GO:0032490) | 2.66463999 |
143 | lipoprotein metabolic process (GO:0042157) | 2.66142670 |
144 | disruption of cells of other organism (GO:0044364) | 2.65928865 |
145 | killing of cells of other organism (GO:0031640) | 2.65928865 |
146 | detection of biotic stimulus (GO:0009595) | 2.65919094 |
147 | mannose metabolic process (GO:0006013) | 2.65582365 |
148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65354493 |
149 | response to host (GO:0075136) | 2.65354493 |
150 | response to host defenses (GO:0052200) | 2.65354493 |
151 | cellular response to interleukin-15 (GO:0071350) | 2.65350000 |
152 | positive regulation of tolerance induction (GO:0002645) | 2.64759472 |
153 | response to nitrosative stress (GO:0051409) | 2.63791391 |
154 | cellular modified amino acid catabolic process (GO:0042219) | 2.63524754 |
155 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62945020 |
156 | serine family amino acid metabolic process (GO:0009069) | 2.62015393 |
157 | regulation of necroptotic process (GO:0060544) | 2.61553895 |
158 | serine family amino acid biosynthetic process (GO:0009070) | 2.60952700 |
159 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.60178134 |
160 | blood coagulation, intrinsic pathway (GO:0007597) | 2.59690589 |
161 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58886578 |
162 | response to host immune response (GO:0052572) | 2.58886578 |
163 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57725626 |
164 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56110123 |
165 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55642160 |
166 | T cell costimulation (GO:0031295) | 2.54879579 |
167 | B cell mediated immunity (GO:0019724) | 2.52814003 |
168 | lymphocyte costimulation (GO:0031294) | 2.50444217 |
169 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50429447 |
170 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50429447 |
171 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50407499 |
172 | positive regulation of interferon-alpha production (GO:0032727) | 2.50137079 |
173 | myeloid dendritic cell activation (GO:0001773) | 2.48223884 |
174 | pinocytosis (GO:0006907) | 2.48217309 |
175 | myeloid dendritic cell differentiation (GO:0043011) | 2.46123181 |
176 | regulation of mast cell degranulation (GO:0043304) | 2.45921100 |
177 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.43775133 |
178 | embryonic process involved in female pregnancy (GO:0060136) | 2.43146247 |
179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42519796 |
180 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.42200274 |
181 | myeloid cell activation involved in immune response (GO:0002275) | 2.41774262 |
182 | negative regulation of innate immune response (GO:0045824) | 2.40763367 |
183 | tolerance induction (GO:0002507) | 2.40244617 |
184 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.39504610 |
185 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.37283669 |
186 | cellular response to interferon-gamma (GO:0071346) | 2.37049203 |
187 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.36789132 |
188 | regulation of regulatory T cell differentiation (GO:0045589) | 2.36777682 |
189 | regulation of granulocyte differentiation (GO:0030852) | 2.36707366 |
190 | regulation of leukocyte degranulation (GO:0043300) | 2.36244784 |
191 | peptide catabolic process (GO:0043171) | 2.35826115 |
192 | T-helper 1 type immune response (GO:0042088) | 2.35813091 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.54724205 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.68004592 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38229783 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.33423694 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.05916154 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68167097 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35248692 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.34166861 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.09499787 |
10 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04852228 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.98253930 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82508055 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.73324872 |
14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60401067 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56355222 |
16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.48392393 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43519387 |
18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26568250 |
19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24038143 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19723121 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10484743 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10371113 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09325057 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04030194 |
25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03539505 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02429039 |
27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01432416 |
28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01098024 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98189844 |
30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94638327 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84217727 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.83862842 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83081119 |
34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77986925 |
35 | MYB_26560356_Chip-Seq_TH2_Human | 1.76894553 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76228850 |
37 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74537141 |
38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72465588 |
39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69383710 |
40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69053891 |
41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68262062 |
42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67269128 |
43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66618897 |
44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64583079 |
45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64286346 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.63818270 |
47 | MYB_26560356_Chip-Seq_TH1_Human | 1.62704933 |
48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54331154 |
49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51984155 |
50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46923844 |
51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45164093 |
52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43076135 |
53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36508812 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34431708 |
55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33927014 |
56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32361208 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29857312 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25515700 |
59 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25355948 |
60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25192367 |
61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23176824 |
62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22856582 |
63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22478285 |
64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22185286 |
65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20696948 |
66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.19912895 |
67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16791038 |
68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15111801 |
69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12349730 |
70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09640257 |
71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07093624 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06593613 |
73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05773902 |
74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05370541 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04590993 |
76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03677329 |
77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01856585 |
78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01063785 |
79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99394517 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98104031 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97493711 |
82 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96402917 |
83 | MAF_26560356_Chip-Seq_TH2_Human | 0.95490710 |
84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94899926 |
85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94824917 |
86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94252514 |
87 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93718310 |
88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93659410 |
89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93424142 |
90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92906471 |
91 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92773418 |
92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91130414 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90959785 |
94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90846290 |
95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90515937 |
96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90495194 |
97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90286790 |
98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89958881 |
99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89926755 |
100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88650418 |
101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87488942 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86038043 |
103 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85534261 |
104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85107700 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85027359 |
106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84444802 |
107 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83920025 |
108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83231034 |
109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82829618 |
110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80232846 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78382884 |
112 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78076487 |
113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77701177 |
114 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76185564 |
115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76148756 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75961558 |
117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75851640 |
118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75626786 |
119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75443679 |
120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.75329875 |
121 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.73606947 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.75521469 |
2 | MP0005360_urolithiasis | 4.64576231 |
3 | MP0005365_abnormal_bile_salt | 3.80953191 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.76367287 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.99802194 |
6 | MP0003252_abnormal_bile_duct | 2.57779662 |
7 | MP0003300_gastrointestinal_ulcer | 2.47234445 |
8 | MP0009840_abnormal_foam_cell | 2.43955001 |
9 | MP0010329_abnormal_lipoprotein_level | 2.37145755 |
10 | * MP0001835_abnormal_antigen_presentation | 2.35534880 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.15724017 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.13963671 |
13 | MP0002166_altered_tumor_susceptibility | 2.04659557 |
14 | MP0002138_abnormal_hepatobiliary_system | 2.02258827 |
15 | MP0003436_decreased_susceptibility_to | 1.97435454 |
16 | MP0003724_increased_susceptibility_to | 1.96052587 |
17 | MP0001666_abnormal_nutrient_absorption | 1.90878854 |
18 | MP0000685_abnormal_immune_system | 1.87792230 |
19 | MP0000609_abnormal_liver_physiology | 1.85995480 |
20 | MP0005671_abnormal_response_to | 1.81846855 |
21 | MP0009785_altered_susceptibility_to | 1.80431055 |
22 | MP0003763_abnormal_thymus_physiology | 1.77521028 |
23 | MP0005083_abnormal_biliary_tract | 1.76429281 |
24 | MP0001800_abnormal_humoral_immune | 1.68491874 |
25 | MP0003183_abnormal_peptide_metabolism | 1.67705206 |
26 | MP0005464_abnormal_platelet_physiology | 1.67270230 |
27 | MP0005387_immune_system_phenotype | 1.62196799 |
28 | MP0001790_abnormal_immune_system | 1.62196799 |
29 | MP0002396_abnormal_hematopoietic_system | 1.60642096 |
30 | MP0005451_abnormal_body_composition | 1.59461170 |
31 | * MP0005025_abnormal_response_to | 1.58637297 |
32 | MP0005332_abnormal_amino_acid | 1.53266220 |
33 | MP0002419_abnormal_innate_immunity | 1.50941861 |
34 | MP0005000_abnormal_immune_tolerance | 1.48865614 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.48482255 |
36 | MP0002998_abnormal_bone_remodeling | 1.46444189 |
37 | MP0003828_pulmonary_edema | 1.44830153 |
38 | MP0002452_abnormal_antigen_presenting | 1.42845236 |
39 | MP0003195_calcinosis | 1.42723694 |
40 | MP0008469_abnormal_protein_level | 1.42005299 |
41 | MP0003303_peritoneal_inflammation | 1.41757314 |
42 | * MP0002723_abnormal_immune_serum | 1.41518889 |
43 | MP0002254_reproductive_system_inflammat | 1.41420533 |
44 | MP0002006_tumorigenesis | 1.41198720 |
45 | MP0001853_heart_inflammation | 1.40925085 |
46 | MP0010155_abnormal_intestine_physiology | 1.37593643 |
47 | MP0002118_abnormal_lipid_homeostasis | 1.34381163 |
48 | MP0001845_abnormal_inflammatory_respons | 1.34139920 |
49 | MP0001873_stomach_inflammation | 1.32941847 |
50 | * MP0002420_abnormal_adaptive_immunity | 1.29609429 |
51 | MP0009643_abnormal_urine_homeostasis | 1.28329388 |
52 | * MP0001819_abnormal_immune_cell | 1.28057359 |
53 | MP0004947_skin_inflammation | 1.27469436 |
54 | MP0003091_abnormal_cell_migration | 1.27427456 |
55 | MP0006082_CNS_inflammation | 1.26899920 |
56 | MP0001851_eye_inflammation | 1.23823846 |
57 | MP0009764_decreased_sensitivity_to | 1.23173193 |
58 | MP0005310_abnormal_salivary_gland | 1.21056203 |
59 | MP0002009_preneoplasia | 1.20244118 |
60 | MP0002405_respiratory_system_inflammati | 1.19902574 |
61 | MP0001764_abnormal_homeostasis | 1.19882297 |
62 | MP0003186_abnormal_redox_activity | 1.18973632 |
63 | MP0000598_abnormal_liver_morphology | 1.17202556 |
64 | MP0003868_abnormal_feces_composition | 1.16908756 |
65 | * MP0002398_abnormal_bone_marrow | 1.15539669 |
66 | MP0008260_abnormal_autophagy | 1.15118944 |
67 | MP0002148_abnormal_hypersensitivity_rea | 1.14637195 |
68 | MP0009763_increased_sensitivity_to | 1.14390584 |
69 | MP0005058_abnormal_lysosome_morphology | 1.13478781 |
70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13272498 |
71 | MP0002933_joint_inflammation | 1.12927699 |
72 | * MP0000689_abnormal_spleen_morphology | 1.11798516 |
73 | * MP0000716_abnormal_immune_system | 1.11514180 |
74 | MP0006054_spinal_hemorrhage | 1.08518067 |
75 | MP0003045_fibrosis | 1.07720122 |
76 | MP0003566_abnormal_cell_adhesion | 1.06632717 |
77 | MP0005164_abnormal_response_to | 1.06503006 |
78 | MP0005397_hematopoietic_system_phenotyp | 1.06093173 |
79 | MP0001545_abnormal_hematopoietic_system | 1.06093173 |
80 | MP0004019_abnormal_vitamin_homeostasis | 1.05555595 |
81 | MP0004883_abnormal_blood_vessel | 1.04032224 |
82 | MP0003448_altered_tumor_morphology | 1.01936076 |
83 | * MP0002722_abnormal_immune_system | 1.01759653 |
84 | MP0008438_abnormal_cutaneous_collagen | 1.01483758 |
85 | MP0000465_gastrointestinal_hemorrhage | 1.01390518 |
86 | MP0003656_abnormal_erythrocyte_physiolo | 0.99370468 |
87 | MP0008004_abnormal_stomach_pH | 0.98777830 |
88 | MP0001533_abnormal_skeleton_physiology | 0.97910478 |
89 | MP0005670_abnormal_white_adipose | 0.97709098 |
90 | MP0003075_altered_response_to | 0.97637423 |
91 | MP0000604_amyloidosis | 0.96785476 |
92 | * MP0002429_abnormal_blood_cell | 0.96395784 |
93 | MP0004264_abnormal_extraembryonic_tissu | 0.95776529 |
94 | MP0010368_abnormal_lymphatic_system | 0.90189744 |
95 | MP0010234_abnormal_vibrissa_follicle | 0.89560975 |
96 | MP0009333_abnormal_splenocyte_physiolog | 0.89197284 |
97 | MP0004381_abnormal_hair_follicle | 0.87664446 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.87575354 |
99 | MP0010352_gastrointestinal_tract_polyps | 0.86931813 |
100 | MP0005220_abnormal_exocrine_pancreas | 0.86632478 |
101 | MP0003866_abnormal_defecation | 0.86026223 |
102 | MP0009697_abnormal_copulation | 0.85623119 |
103 | MP0009115_abnormal_fat_cell | 0.85389436 |
104 | MP0000343_altered_response_to | 0.85222294 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.82959857 |
106 | MP0002136_abnormal_kidney_physiology | 0.82553232 |
107 | MP0005408_hypopigmentation | 0.82470196 |
108 | MP0010307_abnormal_tumor_latency | 0.80461352 |
109 | MP0003690_abnormal_glial_cell | 0.79878254 |
110 | MP0005666_abnormal_adipose_tissue | 0.79392047 |
111 | MP0002132_abnormal_respiratory_system | 0.79317343 |
112 | MP0003172_abnormal_lysosome_physiology | 0.79131780 |
113 | MP0003279_aneurysm | 0.79093624 |
114 | MP0003453_abnormal_keratinocyte_physiol | 0.78753286 |
115 | MP0001958_emphysema | 0.78203335 |
116 | MP0005023_abnormal_wound_healing | 0.77228685 |
117 | MP0001663_abnormal_digestive_system | 0.76961566 |
118 | MP0005390_skeleton_phenotype | 0.76484400 |
119 | MP0009278_abnormal_bone_marrow | 0.76227663 |
120 | MP0009642_abnormal_blood_homeostasis | 0.75951387 |
121 | MP0003705_abnormal_hypodermis_morpholog | 0.75906253 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.75642274 |
123 | MP0005647_abnormal_sex_gland | 0.72036229 |
124 | * MP0000703_abnormal_thymus_morphology | 0.71728965 |
125 | MP0000858_altered_metastatic_potential | 0.71534852 |
126 | MP0005166_decreased_susceptibility_to | 0.71111004 |
127 | MP0005636_abnormal_mineral_homeostasis | 0.70578364 |
128 | MP0000249_abnormal_blood_vessel | 0.70524824 |
129 | MP0004782_abnormal_surfactant_physiolog | 0.69968740 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.83042472 |
2 | Intrahepatic cholestasis (HP:0001406) | 4.72451875 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.65481198 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.46463922 |
5 | Xanthomatosis (HP:0000991) | 4.26117863 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 4.25533210 |
7 | Hypobetalipoproteinemia (HP:0003563) | 4.23667591 |
8 | Complement deficiency (HP:0004431) | 3.99752464 |
9 | Joint hemorrhage (HP:0005261) | 3.90454047 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.73077454 |
11 | Hyperlipoproteinemia (HP:0010980) | 3.57589478 |
12 | Abnormality of macrophages (HP:0004311) | 3.55314863 |
13 | Orchitis (HP:0100796) | 3.32168694 |
14 | Hypoglycemic coma (HP:0001325) | 3.29687725 |
15 | Hypolipoproteinemia (HP:0010981) | 3.13243317 |
16 | Meningitis (HP:0001287) | 3.12763518 |
17 | Myocardial infarction (HP:0001658) | 3.08921898 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.05666902 |
19 | Abnormality of complement system (HP:0005339) | 3.05034628 |
20 | Hyperammonemia (HP:0001987) | 3.03311274 |
21 | Optic neuritis (HP:0100653) | 3.02798138 |
22 | Retrobulbar optic neuritis (HP:0100654) | 3.02798138 |
23 | Fat malabsorption (HP:0002630) | 3.02456818 |
24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00950734 |
25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.00130812 |
26 | Gingival bleeding (HP:0000225) | 2.93071548 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91994605 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91994605 |
29 | Gingivitis (HP:0000230) | 2.91639520 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 2.91541083 |
31 | Cellulitis (HP:0100658) | 2.91238107 |
32 | Epidermoid cyst (HP:0200040) | 2.90997252 |
33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.90768658 |
34 | Ketosis (HP:0001946) | 2.84870708 |
35 | Agammaglobulinemia (HP:0004432) | 2.83331575 |
36 | Increased IgE level (HP:0003212) | 2.81870732 |
37 | T lymphocytopenia (HP:0005403) | 2.80809062 |
38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79695515 |
39 | Systemic lupus erythematosus (HP:0002725) | 2.75525063 |
40 | Abnormality of T cell number (HP:0011839) | 2.74240889 |
41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.72595996 |
42 | Chronic otitis media (HP:0000389) | 2.72551079 |
43 | Autoimmune hemolytic anemia (HP:0001890) | 2.69891521 |
44 | Spontaneous hematomas (HP:0007420) | 2.66859150 |
45 | Eczematoid dermatitis (HP:0000976) | 2.65890478 |
46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.63964042 |
47 | Hypercholesterolemia (HP:0003124) | 2.63793385 |
48 | Pulmonary infiltrates (HP:0002113) | 2.62646697 |
49 | Hypoalphalipoproteinemia (HP:0003233) | 2.62125654 |
50 | Thrombocytosis (HP:0001894) | 2.59762482 |
51 | Abnormality of methionine metabolism (HP:0010901) | 2.58244242 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56731343 |
53 | Recurrent viral infections (HP:0004429) | 2.55447004 |
54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53665217 |
55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51108841 |
56 | Stomatitis (HP:0010280) | 2.50600876 |
57 | Epistaxis (HP:0000421) | 2.50097377 |
58 | Encephalitis (HP:0002383) | 2.47063636 |
59 | Recurrent bronchitis (HP:0002837) | 2.46802107 |
60 | Esophageal varix (HP:0002040) | 2.46684175 |
61 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41529837 |
62 | Malnutrition (HP:0004395) | 2.41466709 |
63 | Thrombophlebitis (HP:0004418) | 2.41395899 |
64 | Osteomyelitis (HP:0002754) | 2.40893350 |
65 | Autoimmune thrombocytopenia (HP:0001973) | 2.40153843 |
66 | Keratoconjunctivitis sicca (HP:0001097) | 2.39842334 |
67 | Hyperbilirubinemia (HP:0002904) | 2.39746427 |
68 | Obstructive lung disease (HP:0006536) | 2.38446139 |
69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38446139 |
70 | Hyperglycinuria (HP:0003108) | 2.38064894 |
71 | Abnormality of T cells (HP:0002843) | 2.36753390 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35495231 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35495231 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35495231 |
75 | Abnormal platelet volume (HP:0011876) | 2.34714242 |
76 | Panhypogammaglobulinemia (HP:0003139) | 2.33687533 |
77 | Gastrointestinal stroma tumor (HP:0100723) | 2.32266497 |
78 | Hemoptysis (HP:0002105) | 2.31936114 |
79 | Pulmonary embolism (HP:0002204) | 2.30810239 |
80 | Chest pain (HP:0100749) | 2.28075392 |
81 | Hepatocellular carcinoma (HP:0001402) | 2.26664516 |
82 | Steatorrhea (HP:0002570) | 2.26654492 |
83 | Acanthocytosis (HP:0001927) | 2.24755909 |
84 | Dysostosis multiplex (HP:0000943) | 2.24700630 |
85 | Hypoplasia of the thymus (HP:0000778) | 2.24689240 |
86 | Increased mean platelet volume (HP:0011877) | 2.24171225 |
87 | Ketoacidosis (HP:0001993) | 2.23768926 |
88 | Granulocytopenia (HP:0001913) | 2.22931289 |
89 | Mitral stenosis (HP:0001718) | 2.22426849 |
90 | Abnormality of glycine metabolism (HP:0010895) | 2.22345290 |
91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.22345290 |
92 | Urticaria (HP:0001025) | 2.21264080 |
93 | Recurrent fungal infections (HP:0002841) | 2.21217784 |
94 | Keratoconjunctivitis (HP:0001096) | 2.20797722 |
95 | IgM deficiency (HP:0002850) | 2.20514428 |
96 | Periodontitis (HP:0000704) | 2.20217957 |
97 | Glomerulonephritis (HP:0000099) | 2.19790694 |
98 | Menorrhagia (HP:0000132) | 2.18596045 |
99 | Abnormality of T cell physiology (HP:0011840) | 2.17426665 |
100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.17247974 |
101 | Hypergammaglobulinemia (HP:0010702) | 2.17092280 |
102 | Joint swelling (HP:0001386) | 2.16916272 |
103 | Leukocytosis (HP:0001974) | 2.16616062 |
104 | Interstitial pulmonary disease (HP:0006530) | 2.14311967 |
105 | Hypoglycemic seizures (HP:0002173) | 2.14025523 |
106 | Arterial thrombosis (HP:0004420) | 2.11176356 |
107 | Hyperglycinemia (HP:0002154) | 2.10095481 |
108 | Vacuolated lymphocytes (HP:0001922) | 2.09817587 |
109 | Spondylolisthesis (HP:0003302) | 2.08764107 |
110 | Myositis (HP:0100614) | 2.07796356 |
111 | Recurrent bacterial skin infections (HP:0005406) | 2.07781919 |
112 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07241441 |
113 | Peritonitis (HP:0002586) | 2.06694315 |
114 | Nasal polyposis (HP:0100582) | 2.06196737 |
115 | Abnormality of the nasal mucosa (HP:0000433) | 2.05266668 |
116 | Abnormality of purine metabolism (HP:0004352) | 2.05107042 |
117 | Viral hepatitis (HP:0006562) | 2.04328851 |
118 | Abnormal platelet function (HP:0011869) | 2.04258134 |
119 | Impaired platelet aggregation (HP:0003540) | 2.04258134 |
120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04025668 |
121 | Spontaneous abortion (HP:0005268) | 2.02449167 |
122 | Amyloidosis (HP:0011034) | 2.01583944 |
123 | Lymphopenia (HP:0001888) | 2.01132738 |
124 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00293389 |
125 | Mucopolysacchariduria (HP:0008155) | 2.00293389 |
126 | Pancreatitis (HP:0001733) | 2.00201977 |
127 | Hemorrhage of the eye (HP:0011885) | 1.99049539 |
128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96879606 |
129 | Gastrointestinal infarctions (HP:0005244) | 1.96699885 |
130 | Colitis (HP:0002583) | 1.95775331 |
131 | Osteolytic defects of the hand bones (HP:0009699) | 1.95513246 |
132 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95513246 |
133 | Increased IgM level (HP:0003496) | 1.95489840 |
134 | Papilloma (HP:0012740) | 1.94613448 |
135 | Verrucae (HP:0200043) | 1.94613448 |
136 | Recurrent skin infections (HP:0001581) | 1.93874702 |
137 | Eosinophilia (HP:0001880) | 1.92757743 |
138 | Inflammation of the large intestine (HP:0002037) | 1.92711922 |
139 | Abnormality of the peritoneum (HP:0002585) | 1.92558387 |
140 | Spastic diplegia (HP:0001264) | 1.92194945 |
141 | Hematochezia (HP:0002573) | 1.91210211 |
142 | Increased cerebral lipofuscin (HP:0011813) | 1.91162519 |
143 | Gastrointestinal inflammation (HP:0004386) | 1.91022806 |
144 | Polycythemia (HP:0001901) | 1.90966215 |
145 | Prolonged bleeding time (HP:0003010) | 1.90655420 |
146 | Emphysema (HP:0002097) | 1.88908636 |
147 | Skin nodule (HP:0200036) | 1.88367400 |
148 | Pustule (HP:0200039) | 1.87789777 |
149 | Vasculitis (HP:0002633) | 1.87615195 |
150 | Skin rash (HP:0000988) | 1.85825542 |
151 | Abnormality of iron homeostasis (HP:0011031) | 1.85676611 |
152 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85650744 |
153 | Chronic diarrhea (HP:0002028) | 1.85135637 |
154 | Skin ulcer (HP:0200042) | 1.84900250 |
155 | Recurrent abscess formation (HP:0002722) | 1.84593084 |
156 | Restrictive lung disease (HP:0002091) | 1.83889451 |
157 | Purpura (HP:0000979) | 1.83686213 |
158 | Fatigue (HP:0012378) | 1.82782907 |
159 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82392101 |
160 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82392101 |
161 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82392101 |
162 | Loss of speech (HP:0002371) | 1.79794671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.48446417 |
2 | PRPF4B | 3.11777772 |
3 | RIPK4 | 3.04650349 |
4 | FGFR4 | 2.95176418 |
5 | ERN1 | 2.93602794 |
6 | TYK2 | 2.65289546 |
7 | BCKDK | 2.56140312 |
8 | JAK3 | 2.50450726 |
9 | TXK | 2.37783355 |
10 | TAOK3 | 2.31854142 |
11 | SIK1 | 2.23633344 |
12 | PKN2 | 2.21594447 |
13 | MAP3K14 | 2.12895611 |
14 | FRK | 2.07594044 |
15 | ZAP70 | 1.99088508 |
16 | IKBKE | 1.98552849 |
17 | FLT3 | 1.95468344 |
18 | TBK1 | 1.93579010 |
19 | TGFBR2 | 1.92818183 |
20 | JAK1 | 1.89744394 |
21 | TRIB3 | 1.81451928 |
22 | KIT | 1.80743309 |
23 | LMTK2 | 1.78422392 |
24 | ITK | 1.72476568 |
25 | BTK | 1.70534904 |
26 | FES | 1.68450831 |
27 | FGFR3 | 1.67965418 |
28 | MAP2K3 | 1.61616839 |
29 | STK10 | 1.56195506 |
30 | MAP3K10 | 1.54162740 |
31 | EEF2K | 1.50017022 |
32 | TEC | 1.48304960 |
33 | IRAK3 | 1.45420655 |
34 | GRK6 | 1.41937147 |
35 | BLK | 1.40040724 |
36 | KDR | 1.39137360 |
37 | IRAK4 | 1.37933950 |
38 | CSF1R | 1.37732362 |
39 | EPHB1 | 1.37025354 |
40 | PTK6 | 1.33455919 |
41 | CSK | 1.27011529 |
42 | NEK9 | 1.24195724 |
43 | TESK2 | 1.21880714 |
44 | JAK2 | 1.21722003 |
45 | IKBKB | 1.20098587 |
46 | INSRR | 1.18574428 |
47 | MAP3K1 | 1.16295018 |
48 | LRRK2 | 1.14882451 |
49 | BMPR2 | 1.12580420 |
50 | CHUK | 1.11417205 |
51 | CDC42BPA | 1.10837412 |
52 | CDK12 | 1.09148611 |
53 | MAP3K3 | 1.08276394 |
54 | SYK | 1.06684931 |
55 | SIK3 | 1.06203297 |
56 | MAPK11 | 1.03326034 |
57 | EIF2AK3 | 1.02511603 |
58 | RIPK1 | 1.02137208 |
59 | KSR2 | 1.01628476 |
60 | LCK | 1.00220522 |
61 | MAP3K2 | 0.98617336 |
62 | MST1R | 0.97240445 |
63 | RPS6KA4 | 0.96806955 |
64 | MAPK7 | 0.89870472 |
65 | NLK | 0.89598111 |
66 | EPHA3 | 0.88070405 |
67 | PRKG2 | 0.86405855 |
68 | MAPK12 | 0.85499510 |
69 | FGR | 0.85464587 |
70 | NME2 | 0.82617697 |
71 | HCK | 0.82470918 |
72 | TGFBR1 | 0.81988517 |
73 | CDK6 | 0.81635199 |
74 | PIK3CG | 0.81211851 |
75 | PIM1 | 0.79952885 |
76 | SMG1 | 0.78935413 |
77 | CDK4 | 0.75913308 |
78 | LYN | 0.74267080 |
79 | TIE1 | 0.74009692 |
80 | PDPK1 | 0.73351217 |
81 | STK4 | 0.69354678 |
82 | CAMK1D | 0.67376667 |
83 | NUAK1 | 0.64803357 |
84 | TNK2 | 0.62982370 |
85 | TTN | 0.61456674 |
86 | PDGFRB | 0.60839941 |
87 | RET | 0.59078833 |
88 | YES1 | 0.59022074 |
89 | PDGFRA | 0.58630560 |
90 | CLK1 | 0.58243050 |
91 | PRKCQ | 0.57549255 |
92 | MARK2 | 0.56310942 |
93 | CAMKK2 | 0.55323369 |
94 | RPS6KB2 | 0.54609607 |
95 | TRPM7 | 0.52774458 |
96 | MELK | 0.51914297 |
97 | MAP3K7 | 0.51378740 |
98 | MAPK4 | 0.50944546 |
99 | TAOK2 | 0.49011533 |
100 | IRAK1 | 0.48994492 |
101 | HIPK2 | 0.48259410 |
102 | PASK | 0.46645850 |
103 | PRKAA2 | 0.46550008 |
104 | MAP3K13 | 0.46414695 |
105 | FGFR2 | 0.44747451 |
106 | MATK | 0.44622272 |
107 | FYN | 0.44267611 |
108 | IGF1R | 0.42885637 |
109 | EGFR | 0.41893356 |
110 | MAP3K11 | 0.41485392 |
111 | WNK1 | 0.41377386 |
112 | STK24 | 0.40579926 |
113 | SCYL2 | 0.40369194 |
114 | MOS | 0.38420293 |
115 | MST4 | 0.38212813 |
116 | MAPK15 | 0.38140791 |
117 | ICK | 0.37971342 |
118 | RPS6KL1 | 0.37548886 |
119 | RPS6KC1 | 0.37548886 |
120 | GRK7 | 0.37473664 |
121 | STK3 | 0.35500977 |
122 | MAP3K8 | 0.34194160 |
123 | RPS6KA6 | 0.34008807 |
124 | ACVR1B | 0.31187765 |
125 | PDK1 | 0.31045245 |
126 | ABL1 | 0.30388573 |
127 | ERBB2 | 0.29351485 |
128 | MAPK3 | 0.29092858 |
129 | PRKCH | 0.27760417 |
130 | SGK3 | 0.27213268 |
131 | PRKCD | 0.27207928 |
132 | MAPKAPK2 | 0.26619793 |
133 | MARK3 | 0.26077094 |
134 | PAK4 | 0.25512110 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.76981701 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05202046 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.99722064 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62085751 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61737488 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.47702034 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.40465484 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36497538 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35975948 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35320102 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.32187596 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27382048 |
13 | Asthma_Homo sapiens_hsa05310 | 2.06294567 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99571844 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88745280 |
16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85062156 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83268219 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82150779 |
19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70628778 |
20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70623705 |
21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70433854 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.70322739 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68183978 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67462280 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57394096 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.56354559 |
27 | ABC transporters_Homo sapiens_hsa02010 | 1.54114767 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52407168 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48097188 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46030742 |
31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45809864 |
32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45208871 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39845207 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31738107 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31723133 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31482249 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23277114 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19811353 |
39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19761834 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17085680 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16789463 |
42 | Bile secretion_Homo sapiens_hsa04976 | 1.14099652 |
43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12722657 |
44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11555863 |
45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11496357 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11467547 |
47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11278259 |
48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10466330 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10221664 |
50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09263958 |
51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08987862 |
52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06788182 |
53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06443214 |
54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05983589 |
55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04756548 |
56 | Platelet activation_Homo sapiens_hsa04611 | 1.04171297 |
57 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03858582 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03596537 |
59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97695025 |
60 | Measles_Homo sapiens_hsa05162 | 0.95140285 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.93357401 |
62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92064318 |
63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90973903 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89978352 |
65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89914007 |
66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89002427 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88728590 |
68 | Lysosome_Homo sapiens_hsa04142 | 0.87582777 |
69 | Phagosome_Homo sapiens_hsa04145 | 0.86529815 |
70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85895502 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85544360 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84895950 |
73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83137346 |
74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83038542 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82950920 |
76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79816483 |
77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74241919 |
78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73827582 |
79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73157918 |
80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72826525 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72571975 |
82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72455249 |
83 | Amoebiasis_Homo sapiens_hsa05146 | 0.72226185 |
84 | Legionellosis_Homo sapiens_hsa05134 | 0.71992027 |
85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71763753 |
86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70968774 |
87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70957682 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68090002 |
89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67480541 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66832829 |
91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66280063 |
92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65932777 |
93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65906824 |
94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64375209 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64163198 |
96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63468087 |
97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62916299 |
98 | Shigellosis_Homo sapiens_hsa05131 | 0.62867478 |
99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62134234 |
100 | Allograft rejection_Homo sapiens_hsa05330 | 0.61899377 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.61716399 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61054879 |
103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57916524 |
104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57192597 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56490273 |
106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56438901 |
107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55706293 |
108 | Pertussis_Homo sapiens_hsa05133 | 0.55346262 |
109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54715246 |
110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54492187 |
111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54352794 |
112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53994051 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53990530 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53650520 |
115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53383783 |
116 | Salmonella infection_Homo sapiens_hsa05132 | 0.52277483 |
117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51884674 |
118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51512195 |
119 | Influenza A_Homo sapiens_hsa05164 | 0.51047720 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50398237 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48777781 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.48724843 |
123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48101991 |
124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47258976 |
125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45649574 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45026737 |
127 | Focal adhesion_Homo sapiens_hsa04510 | 0.44910967 |
128 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44715823 |
129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44544216 |
130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44410425 |
131 | Malaria_Homo sapiens_hsa05144 | 0.43588376 |
132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43523552 |
133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43507969 |
134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43494776 |
135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43397104 |
136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43351430 |
137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42951381 |
138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42457876 |
139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41451411 |
140 | Hepatitis C_Homo sapiens_hsa05160 | 0.41406552 |
141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40651207 |
142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40438911 |
143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40438562 |
144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40282567 |
145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39774053 |
146 | Apoptosis_Homo sapiens_hsa04210 | 0.38154289 |
147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38047413 |
148 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38015778 |
149 | Endocytosis_Homo sapiens_hsa04144 | 0.35930092 |
150 | Prion diseases_Homo sapiens_hsa05020 | 0.35747742 |
151 | Glioma_Homo sapiens_hsa05214 | 0.35115551 |
152 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34720583 |
153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33659251 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33615107 |
155 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33058057 |
156 | Hepatitis B_Homo sapiens_hsa05161 | 0.31630592 |